ARTICLE | Company News
Ostex sales and marketing update
July 31, 1995 7:00 AM UTC
Corning Clinical Laboratories (MetPath) and Corning Nichols Insititute will co-market OSTX's Osteomark bone resorption assay to physicians. The urine test detects bone loss, an indicator for osteoporosis. MetPath (Teterboro, N.J.) and Corning Nichols (San Juan Capistrano, Calif.) have 650 and 65 sales representatives, respectively. ...